Related by context. Frequent words. (Click for all words.) 70 Taiho Pharmaceutical 70 Initiates Phase II 69 Galderma SA 69 TRACON Pharmaceuticals Inc. 68 Therapeutic Competitors Report 68 RhuDex ® 68 Argatroban 67 Completes Patient Enrollment 67 overactive bladder AA# 67 Receives Orphan Drug Designation 67 Fortical R 67 Roche SIX RO 67 MKC# 67 Commences Phase 67 Ophthotech 67 Phase Ib IIa 66 Loramyc R 66 Initiate Phase 66 NV Organon 66 Azur Pharma 66 oncolytic virus therapies 66 Inc. OTCBB BMSN 66 StromaCel Inc. 66 CPL Biologicals 66 * Azixa 65 Onalta 65 VIVITROL ® 65 Loramyc 65 Cetrorelix 65 developing Zerenex TM 65 NASDAQ CRXL 65 Owlstone Nanotech Inc. 65 See BioWorld Today 65 Prism Pharmaceuticals 65 ZALBIN 65 Pharmion Corporation 65 MorphoSys AG FSE MOR 64 Crucell NV NYSE Euronext 64 BioNumerik 64 Geekzone ® SohoSolutions 64 Nippon Shinyaku 64 Meets Primary Endpoint 64 Auxilium transmucosal film 64 InnerCool Therapies 64 Æterna Zentaris Inc. 64 SCHWARZ PHARMA 64 Portola Pharmaceuticals 64 CIMAB SA 64 Dynogen 64 Locteron ® 64 Inhalation Aerosol 64 Rotarix R 64 Teijin Pharma 64 Transcept Pharmaceuticals 64 Completes Enrollment 64 R sorafenib tablets 64 Exploit collaboration 64 Shigamabs ® 64 Astex Therapeutics 64 topical non steroidal 64 ® bortezomib 64 Allovectin 7 64 REUTERS Claro Cortes 64 FACTIVE R gemifloxacin 64 ThermoDox R 64 OncoGenex Technologies 64 BioGlue R 64 Panzem R 64 Nasdaq OSIP 63 AEG# 63 Enrolls First 63 gets USFDA nod 63 Civacir 63 liposomal formulation 63 Application MAA 63 Vaccinex 63 NASDAQ OSIR 63 SIPC CRD # 63 Tibotec Pharmaceuticals Ltd. 63 KNS # 63 ORBOTECH LTD 63 Daclizumab 63 Fresenius Kabi AG 63 Aloxi R 63 A5 Laboratories 63 BioTie 63 inhaled formulation 63 Crucell NV Euronext 63 PRNewswire FirstCall Labopharm 63 OTCBB ENTB 63 Nippon Kayaku 63 apaziquone 63 PAION AG 63 Phase IIb clinical trials 63 Primus Pharmaceuticals 63 trastuzumab DM1 T DM1 63 Nexavar ® 63 AmpliMed 63 Ixempra 63 FluoroPharma 63 MuGard TM